AAN 2024: Importance of early diagnosis and prompt treatment in SMA
By Admin | April 14, 2024
A key theme from the spinal muscular atrophy (SMA) presentations at the American Academy of Neurology (AAN) 2024 Annual Meeting is the need for early diagnosis and treatment intervention in patients.
Initiating pharmacological treatment during the presymptomatic stages of SMA, prior to the onset of symptoms, could help patients achieve normal childhood developmental milestones.
SMA is characterised by a loss of lower motor neurons in the spinal cord, resulting in progressive muscle weakness and functional decline, including muscle wasting (atrophy) and low muscle tone (hypotonia) that is more commonly observed in the proximal muscles such as the shoulders, hips, and back.
Neurons controlling most voluntary muscles such as those involved in feeding, swallowing, and...(More)
For more info please read, AAN 2024: Importance of early diagnosis and prompt treatment in SMA, by Clinical Trials Arena
